AMR Archives - Vivli AMR

Breaking News – Vivli announces the 2025 AMR Surveillance Data Challenge to Initiate April 15th

Vivli is excited to announce the launch of the 2025 Vivli AMR Surveillance Data Challenge, opening on April 15, 2025. Now in its third year, this global competition is funded by Johnson & Johnson, Paratek, Pfizer, and an NIH award* and is designed to stimulate innovative reuse of antimicrobial resistance (AMR) surveillance data housed in the AMR Register.

This Challenge invites multidisciplinary research teams to harness high-quality industry AMR surveillance data to tackle critical questions in AMR. Participants will compete for prestigious awards by generating new insights that contribute to the global fight against antimicrobial resistance.

Participants will use high-quality industry data from the AMR Register, which has been significantly expanded this year with new datasets and refreshed with new datasets. This is a unique opportunity for researchers across disciplines to generate fresh insights and contribute meaningfully to the global effort to combat AMR.

What prizes can be won?

A total of 5 awards will be provided that are associated with monetary awards and/or travel

2 Grand Prize Awards –
- AMR Global Leadership Award Grand Prize
- AMR Visionary Award Grand Prize
  - Each for $10,000 and a travel grant of $5,000 to travel to an infectious disease conference 2026 if an abstract is accepted
1 AMR Student Innovation Award –receiving a travel grant of $5,000 to travel to an infectious disease conference in 2026, if their abstract is accepted
2 Awards – 1 Award in AMR Impact, 1 Award in AMR Innovation; Each receiving $5,000 and a travel grant of $2,000 to travel to an infectious disease conference in 2026, if their abstract is accepted

Sign up to the data challenge Slack Channel to be notified when the challenge is open and to keep updated about the latest information and details about this data challenge.

* Funded in part by NIH Award
Generalist Repository Ecosystem Initiative (GREI)
Other Transaction Agreement No.: 1OT2DB000003-

AMR Webinar: NIH’s Data Sharing and Reuse Seminar Series: The Vivli AMR Data Challenge as a Use Case

This webinar, hosted by the NIH, explores the critical role of data sharing and re-use and demonstrates how data sharing can be effective using a case study in the area of anti-microbial resistance (AMR) using the real-world AMR data challenge as a use case. Experts and Global Grand prize data challenge awardees from 2023 and 2024 discuss best practices for overcoming barriers to data accessibility, ensuring responsible re-use, and fostering international collaboration through the mechanism of a data challenge. A key focus is the AMR Register run by Vivli, a global data-sharing platform designed to facilitate access to antimicrobial resistance data, enhance transparency, and drive innovative solutions in AMR research.

Learn More

Speakers:

Kasim Allel, Ph.D., Researcher, University of Oxford, UK and AMR Global Grand Prize data challenge awardee 2024
Fred Mutisya, M.D., Field Epidemiology Resident, Kenya and AMR Global Grand Prize data challenge awardee 2023, AMR Global Impact data challenge awardee 2024
Patricia Bradford, Ph.D., Microbiology Consultant, Antimicrobial Development Specialists, LLC
Rebecca Li, Ph.D., Vivli CEO and Board Member

Learn More

AMR Data Challenge Winners Awarded Prizes at ECCMID

Rebecca Li congratulates Grand Prize winner Dr. Fredrick Mutisya

We’re thrilled to honor the recipients of the 2023 Vivli Antimicrobial Resistance Surveillance Open Data Re-Use Data Challenge, generously sponsored by Wellcome. At a special gathering during ESCMID 2024 in Barcelona, teams presented their solutions, showcasing the transformative potential of data re-use in addressing global health challenges like antimicrobial resistance.

“At Vivli, our dedication to healthcare innovation is unwavering,” said Rebecca Li, Vivli CEO. “The innovations unveiled at the 2023 Vivli AMR Surveillance Data Challenge underscore the vital role of collaboration and data-driven strategies in the fight against antimicrobial resistance. Together, we’re shaping the future of global health.

As a scientist, it was gratifying to meet with the winners of the challenge and hear more about their innovative solutions and findings from their analysis of the pharmaceutical surveillance data. Our heartfelt gratitude goes to Wellcome for their invaluable support, and to our data contributors and all participants who played a pivotal role in this challenge.”

The Vivli AMR Surveillance Open Data Re-Use Data Challenge, funded by Wellcome was designed to foster awareness and incentivize the repurposing of surveillance data available in the AMR Register. Attracting 56 teams from 28 nations, this event served as a catalyst for cross-disciplinary collaboration and empowered participants to leverage the wealth of high-quality AMR surveillance data generously contributed by GSK, Johnson & Johnson, Paratek, Pfizer, Shionogi, and Venatorx.